These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28740230)

  • 21. Visceral symptoms as a key diagnostic sign for the early infantile form of Niemann-Pick disease type C in a Russian patient: a case report.
    Degtyareva AV; Mikhailova SV; Zakharova EY; Tumanova EL; Puchkova AA
    J Med Case Rep; 2016 Jun; 10(1):143. PubMed ID: 27250337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice.
    Hovakimyan M; Maass F; Petersen J; Holzmann C; Witt M; Lukas J; Frech MJ; Hübner R; Rolfs A; Wree A
    Neuroscience; 2013 Nov; 252():201-11. PubMed ID: 23948640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat.
    Sedel F; Chabrol B; Audoin B; Kaphan E; Tranchant C; Burzykowski T; Tourbah A; Vanier MT; Galanaud D
    J Neurol; 2016 May; 263(5):927-936. PubMed ID: 26984608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A therapy with miglustat, 2-hydroxypropyl-ß-cyclodextrin and allopregnanolone restores splenic cholesterol homeostasis in Niemann-pick disease type C1.
    Neßlauer AM; Gläser A; Gräler M; Engelmann R; Müller-Hilke B; Frank M; Burstein C; Rolfs A; Neidhardt J; Wree A; Witt M; Bräuer AU
    Lipids Health Dis; 2019 Jun; 18(1):146. PubMed ID: 31248418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Miglustat in Niemann-Pick disease type C patients: a review.
    Pineda M; Walterfang M; Patterson MC
    Orphanet J Rare Dis; 2018 Aug; 13(1):140. PubMed ID: 30111334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.
    Karimzadeh P; Tonekaboni SH; Ashrafi MR; Shafeghati Y; Rezayi A; Salehpour S; Ghofrani M; Taghdiri MM; Rahmanifar A; Zaman T; Aryani O; Shoar BN; Shiva F; Tavasoli A; Houshmand M
    J Child Neurol; 2013 Dec; 28(12):1599-606. PubMed ID: 23143717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased Regenerative Capacity of the Olfactory Epithelium in Niemann-Pick Disease Type C1.
    Meyer A; Wree A; Günther R; Holzmann C; Schmitt O; Rolfs A; Witt M
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28383485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Main Olfactory and Vomeronasal Epithelium Are Differently Affected in Niemann-Pick Disease Type C1.
    Witt M; Thiemer R; Meyer A; Schmitt O; Wree A
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30424529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: a prospective observational study.
    De Castro-Orós I; Irún P; Cebolla JJ; Rodriguez-Sureda V; Mallén M; Pueyo MJ; Mozas P; Dominguez C; Pocoví M;
    J Transl Med; 2017 Feb; 15(1):43. PubMed ID: 28222799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neurofilament light chain in cerebrospinal fluid as a novel biomarker in evaluating both clinical severity and therapeutic response in Niemann-Pick disease type C1.
    Agrawal N; Farhat NY; Sinaii N; Do AD; Xiao C; Berry-Kravis E; Bianconi S; Masvekar R; Bielekova B; Solomon B; Porter FD
    Genet Med; 2023 Mar; 25(3):100349. PubMed ID: 36470574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease characteristics, prognosis and miglustat treatment effects on disease progression in patients with Niemann-Pick disease Type C: an international, multicenter, retrospective chart review.
    Pineda M; Juríčková K; Karimzadeh P; Kolnikova M; Malinova V; Insua JL; Velten C; Kolb SA
    Orphanet J Rare Dis; 2019 Jan; 14(1):32. PubMed ID: 30732631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender-Specific Effects of Two Treatment Strategies in a Mouse Model of Niemann-Pick Disease Type C1.
    Holzmann C; Witt M; Rolfs A; Antipova V; Wree A
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corneal alterations during combined therapy with cyclodextrin/allopregnanolone and miglustat in a knock-out mouse model of NPC1 disease.
    Hovakimyan M; Petersen J; Maass F; Reichard M; Witt M; Lukas J; Stachs O; Guthoff R; Rolfs A; Wree A
    PLoS One; 2011; 6(12):e28418. PubMed ID: 22163015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative acidic compartment volume as a lysosomal storage disorder-associated biomarker.
    te Vruchte D; Speak AO; Wallom KL; Al Eisa N; Smith DA; Hendriksz CJ; Simmons L; Lachmann RH; Cousins A; Hartung R; Mengel E; Runz H; Beck M; Amraoui Y; Imrie J; Jacklin E; Riddick K; Yanjanin NM; Wassif CA; Rolfs A; Rimmele F; Wright N; Taylor C; Ramaswami U; Cox TM; Hastings C; Jiang X; Sidhu R; Ory DS; Arias B; Jeyakumar M; Sillence DJ; Wraith JE; Porter FD; Cortina-Borja M; Platt FM
    J Clin Invest; 2014 Mar; 124(3):1320-8. PubMed ID: 24487591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of miglustat in Niemann-Pick C disease: a single centre experience.
    Ginocchio VM; D'Amico A; Bertini E; Ceravolo F; Dardis A; Verrigni D; Bembi B; Dionisi-Vici C; Deodato F
    Mol Genet Metab; 2013 Nov; 110(3):329-35. PubMed ID: 23973268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Adult onset Niemann-Pick type C disease and psychosis: literature review].
    Maubert A; Hanon C; Metton JP
    Encephale; 2013 Oct; 39(5):315-9. PubMed ID: 23928063
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.
    Cologna SM; Jiang XS; Backlund PS; Cluzeau CV; Dail MK; Yanjanin NM; Siebel S; Toth CL; Jun HS; Wassif CA; Yergey AL; Porter FD
    PLoS One; 2012; 7(10):e47845. PubMed ID: 23144710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of N-acetylcysteine in phenotypic suppression of mouse models of Niemann-Pick disease, type C1.
    Fu R; Wassif CA; Yanjanin NM; Watkins-Chow DE; Baxter LL; Incao A; Liscum L; Sidhu R; Firnkes S; Graham M; Ory DS; Porter FD; Pavan WJ
    Hum Mol Genet; 2013 Sep; 22(17):3508-23. PubMed ID: 23666527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Niemann-Pick type C disease and psychosis: Two siblings].
    Maubert A; Hanon C; Metton JP
    Encephale; 2015 Jun; 41(3):238-43. PubMed ID: 25238906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease.
    Giese AK; Mascher H; Grittner U; Eichler S; Kramp G; Lukas J; te Vruchte D; Al Eisa N; Cortina-Borja M; Porter FD; Platt FM; Rolfs A
    Orphanet J Rare Dis; 2015 Jun; 10():78. PubMed ID: 26082315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.